Hepatitis B Vaccine Series Completion by 18 Months in Infants Without a Birth Dose

Jim Williams; Hannah Cruz; Amy Stein; Kristin Breslin; Michaela Brtnikova; Bradley Crane; Stephanie A. Irving; Sungching Glenn; Tat’Yana Kenigsberg; Bruno Lewin; Sara Tartof; Maria E. Sundaram; Sharon Fuller; Teresa Schmidt; Sean O’Leary; Daniela Canedo; Jason M. Glanz; Malini Desilva; Candace C. Fuller; Ousseny Zerbo; Simon J. Hambidge

doi:10.1001/jamanetworkopen.2026.9962

Key Points

To assess the completion rates of the hepatitis B vaccination series by 18 months in infants with and without a birth dose.
Cohort study design comparing two groups of infants: those who received a birth dose of the hepatitis B vaccine and those who did not.
Outcomes measured include the rate of completion of the hepatitis B vaccination series by 18 months.
Infants who received a birth dose showed higher completion rates of the hepatitis B vaccine series by 18 months.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Cohort study compares hepatitis B vaccination completion by 18 months in infants lacking a birth dose, suggesting implications for immunization practices.

Abstract

This cohort study compares hepatitis B vaccination series completion by 18 months in infants who did vs did not receive a birth dose.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Williams et al. (2026) studied this question.

synapsesocial.com/papers/69edabdf4a46254e215b3b0e https://doi.org/10.1001/jamanetworkopen.2026.9962

View Full Paper

Ask AI

Bookmark

Share

Hepatitis B Vaccine Series Completion by 18 Months in Infants Without a Birth Dose

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Hepatitis B Vaccine Series Completion by 18 Months in Infants Without a Birth Dose

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading